The Media Database That Really Understands Journalists

Explore Our Database And See What Journalists Create So You Can Better Connect 🫶

Find Out More

Media Database B barrons.com Josh Nathan-Kazis

Josh Nathan-Kazis
joshnathankazis

6216 followers

New York, NY

Covering healthcare companies for Barron's. Opinions my own. Subscribe for updates: https://t.co/CKk7YBnxNM

Publications:
Topics
biotech and pharma, biotechnology services, c&e industry news filter, content types, corporate, corporate/industrial news, factiva filters, financial performance, general news, health, healthcare, healthcare/life sciences, industrial news, jewish, journalists, life sciences, medical conditions, news, news/journalists/photos, pharmaceuticals, political, political/general news, politics, press, retail, synd, lly
Recent articles
Sell Hims & Hers Stock. The Weight-Loss Drug Surge Is Fading Fast.
Mar 06, 2025
barrons.com
Hims & Hers Stock Is Due for a Crash Diet. The GLP-1 Surge Is Fading Fast.
Mar 06, 2025
barrons.com
Novo Nordisk’s Cheaper Wegovy Offering Is Bad News for Hims & Hers
Mar 05, 2025
barrons.com
Healthcare Stocks Avoid Tariff Damage. There Are Other Problems.
Mar 04, 2025
barrons.com
Pfizer Hires Top FDA Official Dr. Cavazzoni Just Weeks After She Leaves Agency
Feb 24, 2025
barrons.com
Healthcare Stocks to Invest in, According to a Veteran Healthcare Analyst
Dec 19, 2024
barrons.com
J&J Needs to End Talc Lawsuits. The Third Time Could Be the Charm.
Sep 23, 2024
barrons.com
FDA Approves Eli Lilly’s Alzheimer’s Drug
Jul 02, 2024
barrons.com
Vertex Pharmaceuticals CEO Reshma Kewalramani
Jun 21, 2024
barrons.com
FDA Advisers Like Lilly’s Alzheimer’s Drug. It’s Good News for Biogen.
Jun 11, 2024
barrons.com

Find out everything there is to know

Publication resume, most loved topics, and more. Find out everything there is to know about a journalist, in our 500k+ database.

Start a free trial of BuzzSumo.

START YOUR FREE TRIAL

Already registered? Log in to your account